ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Management of Antithrombin Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-33R17269
Home | Market Reports | Health| Pharmacy
Global Management of Antithrombin Market Research Report 2024
BUY CHAPTERS

Global Management of Antithrombin Market Research Report 2024

Code: QYRE-Auto-33R17269
Report
June 2024
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Grifols S A
REVO Biologics Inc
Takeda
Kedrion S p A
CSL Limited
Scripps Laboratories Inc
Lee Biosolutions

Management of Antithrombin Market

Management of Antithrombin is a protein in the blood that plays a crucial role in regulating blood clotting. It is a natural anticoagulant that inhibits or blocks the activity of certain clotting factors, specifically thrombin and factor Xa, preventing excessive clotting and maintaining blood flow.
The global Management of Antithrombin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Management of Antithrombin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Management of Antithrombin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Management of Antithrombin in Diagnostics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Management of Antithrombin include Grifols, rEVO Biologics Inc., Takeda, Kedrion S.p.A., CSL Limited, Scripps Laboratories Inc., Lee Biosolutions, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Management of Antithrombin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Management of Antithrombin.
The Management of Antithrombin market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Management of Antithrombin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Management of Antithrombin companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Management of Antithrombin Market Report

Report Metric Details
Report Name Management of Antithrombin Market
Segment by Type
  • Liquid
  • Lyophilized
Segment by Application
  • Diagnostics
  • Therapeutics
  • Research
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Grifols, rEVO Biologics Inc., Takeda, Kedrion S.p.A., CSL Limited, Scripps Laboratories Inc., Lee Biosolutions
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Management of Antithrombin company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Management of Antithrombin Market report?

Ans: The main players in the Management of Antithrombin Market are Grifols, rEVO Biologics Inc., Takeda, Kedrion S.p.A., CSL Limited, Scripps Laboratories Inc., Lee Biosolutions

What are the Application segmentation covered in the Management of Antithrombin Market report?

Ans: The Applications covered in the Management of Antithrombin Market report are Diagnostics, Therapeutics, Research

What are the Type segmentation covered in the Management of Antithrombin Market report?

Ans: The Types covered in the Management of Antithrombin Market report are Liquid, Lyophilized

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Management of Antithrombin Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Liquid
1.2.3 Lyophilized
1.3 Market by Application
1.3.1 Global Management of Antithrombin Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diagnostics
1.3.3 Therapeutics
1.3.4 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Management of Antithrombin Market Perspective (2019-2030)
2.2 Global Management of Antithrombin Growth Trends by Region
2.2.1 Global Management of Antithrombin Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Management of Antithrombin Historic Market Size by Region (2019-2024)
2.2.3 Management of Antithrombin Forecasted Market Size by Region (2025-2030)
2.3 Management of Antithrombin Market Dynamics
2.3.1 Management of Antithrombin Industry Trends
2.3.2 Management of Antithrombin Market Drivers
2.3.3 Management of Antithrombin Market Challenges
2.3.4 Management of Antithrombin Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Management of Antithrombin Players by Revenue
3.1.1 Global Top Management of Antithrombin Players by Revenue (2019-2024)
3.1.2 Global Management of Antithrombin Revenue Market Share by Players (2019-2024)
3.2 Global Management of Antithrombin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Management of Antithrombin Revenue
3.4 Global Management of Antithrombin Market Concentration Ratio
3.4.1 Global Management of Antithrombin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Management of Antithrombin Revenue in 2023
3.5 Global Key Players of Management of Antithrombin Head office and Area Served
3.6 Global Key Players of Management of Antithrombin, Product and Application
3.7 Global Key Players of Management of Antithrombin, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Management of Antithrombin Breakdown Data by Type
4.1 Global Management of Antithrombin Historic Market Size by Type (2019-2024)
4.2 Global Management of Antithrombin Forecasted Market Size by Type (2025-2030)
5 Management of Antithrombin Breakdown Data by Application
5.1 Global Management of Antithrombin Historic Market Size by Application (2019-2024)
5.2 Global Management of Antithrombin Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Management of Antithrombin Market Size (2019-2030)
6.2 North America Management of Antithrombin Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Management of Antithrombin Market Size by Country (2019-2024)
6.4 North America Management of Antithrombin Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Management of Antithrombin Market Size (2019-2030)
7.2 Europe Management of Antithrombin Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Management of Antithrombin Market Size by Country (2019-2024)
7.4 Europe Management of Antithrombin Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Management of Antithrombin Market Size (2019-2030)
8.2 Asia-Pacific Management of Antithrombin Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Management of Antithrombin Market Size by Region (2019-2024)
8.4 Asia-Pacific Management of Antithrombin Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Management of Antithrombin Market Size (2019-2030)
9.2 Latin America Management of Antithrombin Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Management of Antithrombin Market Size by Country (2019-2024)
9.4 Latin America Management of Antithrombin Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Management of Antithrombin Market Size (2019-2030)
10.2 Middle East & Africa Management of Antithrombin Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Management of Antithrombin Market Size by Country (2019-2024)
10.4 Middle East & Africa Management of Antithrombin Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Grifols
11.1.1 Grifols Company Details
11.1.2 Grifols Business Overview
11.1.3 Grifols Management of Antithrombin Introduction
11.1.4 Grifols Revenue in Management of Antithrombin Business (2019-2024)
11.1.5 Grifols Recent Development
11.2 rEVO Biologics Inc.
11.2.1 rEVO Biologics Inc. Company Details
11.2.2 rEVO Biologics Inc. Business Overview
11.2.3 rEVO Biologics Inc. Management of Antithrombin Introduction
11.2.4 rEVO Biologics Inc. Revenue in Management of Antithrombin Business (2019-2024)
11.2.5 rEVO Biologics Inc. Recent Development
11.3 Takeda
11.3.1 Takeda Company Details
11.3.2 Takeda Business Overview
11.3.3 Takeda Management of Antithrombin Introduction
11.3.4 Takeda Revenue in Management of Antithrombin Business (2019-2024)
11.3.5 Takeda Recent Development
11.4 Kedrion S.p.A.
11.4.1 Kedrion S.p.A. Company Details
11.4.2 Kedrion S.p.A. Business Overview
11.4.3 Kedrion S.p.A. Management of Antithrombin Introduction
11.4.4 Kedrion S.p.A. Revenue in Management of Antithrombin Business (2019-2024)
11.4.5 Kedrion S.p.A. Recent Development
11.5 CSL Limited
11.5.1 CSL Limited Company Details
11.5.2 CSL Limited Business Overview
11.5.3 CSL Limited Management of Antithrombin Introduction
11.5.4 CSL Limited Revenue in Management of Antithrombin Business (2019-2024)
11.5.5 CSL Limited Recent Development
11.6 Scripps Laboratories Inc.
11.6.1 Scripps Laboratories Inc. Company Details
11.6.2 Scripps Laboratories Inc. Business Overview
11.6.3 Scripps Laboratories Inc. Management of Antithrombin Introduction
11.6.4 Scripps Laboratories Inc. Revenue in Management of Antithrombin Business (2019-2024)
11.6.5 Scripps Laboratories Inc. Recent Development
11.7 Lee Biosolutions
11.7.1 Lee Biosolutions Company Details
11.7.2 Lee Biosolutions Business Overview
11.7.3 Lee Biosolutions Management of Antithrombin Introduction
11.7.4 Lee Biosolutions Revenue in Management of Antithrombin Business (2019-2024)
11.7.5 Lee Biosolutions Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Grifols S A
REVO Biologics Inc
Takeda
Kedrion S p A
CSL Limited
Scripps Laboratories Inc
Lee Biosolutions
List of Tables
 Table 1. Global Management of Antithrombin Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Liquid
 Table 3. Key Players of Lyophilized
 Table 4. Global Management of Antithrombin Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 5. Global Management of Antithrombin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Management of Antithrombin Market Size by Region (2019-2024) & (US$ Million)
 Table 7. Global Management of Antithrombin Market Share by Region (2019-2024)
 Table 8. Global Management of Antithrombin Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 9. Global Management of Antithrombin Market Share by Region (2025-2030)
 Table 10. Management of Antithrombin Market Trends
 Table 11. Management of Antithrombin Market Drivers
 Table 12. Management of Antithrombin Market Challenges
 Table 13. Management of Antithrombin Market Restraints
 Table 14. Global Management of Antithrombin Revenue by Players (2019-2024) & (US$ Million)
 Table 15. Global Management of Antithrombin Market Share by Players (2019-2024)
 Table 16. Global Top Management of Antithrombin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Management of Antithrombin as of 2023)
 Table 17. Ranking of Global Top Management of Antithrombin Companies by Revenue (US$ Million) in 2023
 Table 18. Global 5 Largest Players Market Share by Management of Antithrombin Revenue (CR5 and HHI) & (2019-2024)
 Table 19. Global Key Players of Management of Antithrombin, Headquarters and Area Served
 Table 20. Global Key Players of Management of Antithrombin, Product and Application
 Table 21. Global Key Players of Management of Antithrombin, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Management of Antithrombin Market Size by Type (2019-2024) & (US$ Million)
 Table 24. Global Management of Antithrombin Revenue Market Share by Type (2019-2024)
 Table 25. Global Management of Antithrombin Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 26. Global Management of Antithrombin Revenue Market Share by Type (2025-2030)
 Table 27. Global Management of Antithrombin Market Size by Application (2019-2024) & (US$ Million)
 Table 28. Global Management of Antithrombin Revenue Market Share by Application (2019-2024)
 Table 29. Global Management of Antithrombin Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 30. Global Management of Antithrombin Revenue Market Share by Application (2025-2030)
 Table 31. North America Management of Antithrombin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 32. North America Management of Antithrombin Market Size by Country (2019-2024) & (US$ Million)
 Table 33. North America Management of Antithrombin Market Size by Country (2025-2030) & (US$ Million)
 Table 34. Europe Management of Antithrombin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 35. Europe Management of Antithrombin Market Size by Country (2019-2024) & (US$ Million)
 Table 36. Europe Management of Antithrombin Market Size by Country (2025-2030) & (US$ Million)
 Table 37. Asia-Pacific Management of Antithrombin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 38. Asia-Pacific Management of Antithrombin Market Size by Region (2019-2024) & (US$ Million)
 Table 39. Asia-Pacific Management of Antithrombin Market Size by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Management of Antithrombin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 41. Latin America Management of Antithrombin Market Size by Country (2019-2024) & (US$ Million)
 Table 42. Latin America Management of Antithrombin Market Size by Country (2025-2030) & (US$ Million)
 Table 43. Middle East & Africa Management of Antithrombin Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 44. Middle East & Africa Management of Antithrombin Market Size by Country (2019-2024) & (US$ Million)
 Table 45. Middle East & Africa Management of Antithrombin Market Size by Country (2025-2030) & (US$ Million)
 Table 46. Grifols Company Details
 Table 47. Grifols Business Overview
 Table 48. Grifols Management of Antithrombin Product
 Table 49. Grifols Revenue in Management of Antithrombin Business (2019-2024) & (US$ Million)
 Table 50. Grifols Recent Development
 Table 51. rEVO Biologics Inc. Company Details
 Table 52. rEVO Biologics Inc. Business Overview
 Table 53. rEVO Biologics Inc. Management of Antithrombin Product
 Table 54. rEVO Biologics Inc. Revenue in Management of Antithrombin Business (2019-2024) & (US$ Million)
 Table 55. rEVO Biologics Inc. Recent Development
 Table 56. Takeda Company Details
 Table 57. Takeda Business Overview
 Table 58. Takeda Management of Antithrombin Product
 Table 59. Takeda Revenue in Management of Antithrombin Business (2019-2024) & (US$ Million)
 Table 60. Takeda Recent Development
 Table 61. Kedrion S.p.A. Company Details
 Table 62. Kedrion S.p.A. Business Overview
 Table 63. Kedrion S.p.A. Management of Antithrombin Product
 Table 64. Kedrion S.p.A. Revenue in Management of Antithrombin Business (2019-2024) & (US$ Million)
 Table 65. Kedrion S.p.A. Recent Development
 Table 66. CSL Limited Company Details
 Table 67. CSL Limited Business Overview
 Table 68. CSL Limited Management of Antithrombin Product
 Table 69. CSL Limited Revenue in Management of Antithrombin Business (2019-2024) & (US$ Million)
 Table 70. CSL Limited Recent Development
 Table 71. Scripps Laboratories Inc. Company Details
 Table 72. Scripps Laboratories Inc. Business Overview
 Table 73. Scripps Laboratories Inc. Management of Antithrombin Product
 Table 74. Scripps Laboratories Inc. Revenue in Management of Antithrombin Business (2019-2024) & (US$ Million)
 Table 75. Scripps Laboratories Inc. Recent Development
 Table 76. Lee Biosolutions Company Details
 Table 77. Lee Biosolutions Business Overview
 Table 78. Lee Biosolutions Management of Antithrombin Product
 Table 79. Lee Biosolutions Revenue in Management of Antithrombin Business (2019-2024) & (US$ Million)
 Table 80. Lee Biosolutions Recent Development
 Table 81. Research Programs/Design for This Report
 Table 82. Key Data Information from Secondary Sources
 Table 83. Key Data Information from Primary Sources
 Table 84. Authors List of This Report


List of Figures
 Figure 1. Management of Antithrombin Picture
 Figure 2. Global Management of Antithrombin Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Management of Antithrombin Market Share by Type: 2023 VS 2030
 Figure 4. Liquid Features
 Figure 5. Lyophilized Features
 Figure 6. Global Management of Antithrombin Market Size by Application (2024-2030) & (US$ Million)
 Figure 7. Global Management of Antithrombin Market Share by Application: 2023 VS 2030
 Figure 8. Diagnostics Case Studies
 Figure 9. Therapeutics Case Studies
 Figure 10. Research Case Studies
 Figure 11. Management of Antithrombin Report Years Considered
 Figure 12. Global Management of Antithrombin Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 13. Global Management of Antithrombin Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 14. Global Management of Antithrombin Market Share by Region: 2023 VS 2030
 Figure 15. Global Management of Antithrombin Market Share by Players in 2023
 Figure 16. Global Top Management of Antithrombin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Management of Antithrombin as of 2023)
 Figure 17. The Top 10 and 5 Players Market Share by Management of Antithrombin Revenue in 2023
 Figure 18. North America Management of Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 19. North America Management of Antithrombin Market Share by Country (2019-2030)
 Figure 20. United States Management of Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. Canada Management of Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Europe Management of Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Europe Management of Antithrombin Market Share by Country (2019-2030)
 Figure 24. Germany Management of Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. France Management of Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. U.K. Management of Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. Italy Management of Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. Russia Management of Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Nordic Countries Management of Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Asia-Pacific Management of Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Asia-Pacific Management of Antithrombin Market Share by Region (2019-2030)
 Figure 32. China Management of Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Japan Management of Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. South Korea Management of Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Southeast Asia Management of Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. India Management of Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Australia Management of Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Latin America Management of Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Latin America Management of Antithrombin Market Share by Country (2019-2030)
 Figure 40. Mexico Management of Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Brazil Management of Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Middle East & Africa Management of Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Middle East & Africa Management of Antithrombin Market Share by Country (2019-2030)
 Figure 44. Turkey Management of Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Saudi Arabia Management of Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. UAE Management of Antithrombin Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. Grifols Revenue Growth Rate in Management of Antithrombin Business (2019-2024)
 Figure 48. rEVO Biologics Inc. Revenue Growth Rate in Management of Antithrombin Business (2019-2024)
 Figure 49. Takeda Revenue Growth Rate in Management of Antithrombin Business (2019-2024)
 Figure 50. Kedrion S.p.A. Revenue Growth Rate in Management of Antithrombin Business (2019-2024)
 Figure 51. CSL Limited Revenue Growth Rate in Management of Antithrombin Business (2019-2024)
 Figure 52. Scripps Laboratories Inc. Revenue Growth Rate in Management of Antithrombin Business (2019-2024)
 Figure 53. Lee Biosolutions Revenue Growth Rate in Management of Antithrombin Business (2019-2024)
 Figure 54. Bottom-up and Top-down Approaches for This Report
 Figure 55. Data Triangulation
 Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Antithrombin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Thrombin Inhibitor Market Research Report 2024
Humanes Antithrombin III Konzentrat Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti thrombin III Testing Market Insights Forecast to 2030
Global Factor Xa Inhibitors Market Research Report 2024
Global Human Thrombin Market Research Report 2024
Global Recombinant Human Thrombin Protein Market Research Report 2024
Global Anticoagulant Medicines Market Research Report 2025
Global Anticoagulant Drugs Market Insights Forecast to 2030
Global Antithrombotic Treatment Market Insights Forecast to 2030
Thrombin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anticoagulant Treatment Market Insights Forecast to 2030
Global Heparin Market Insights Forecast to 2030
Antihemophilic Factor Recombinant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Human Thrombin for Surgical Hemostasis Market Research Report 2024
Global Human Antithrombin III Market Research Report 2024
Global Intravenous Anticoagulants Market Research Report 2024
Global Rivaroxaban Drugs Market Research Report 2024
Global Thrombosis Drug Market Research Report 2025
Recombinant Hirudin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions